All Stories

  1. Impact of the MEESSI-AHF tool to guide disposition decision-making in patients with acute heart failure in the emergency department: a before-and-after study
  2. Determinants of Progression and Regression of Subclinical Atherosclerosis Over 6 Years
  3. Impacto de la fracción de eyección del ventrículo izquierdo en el consumo de recursos, los costes y el pronóstico en pacientes con insuficiencia cardiaca
  4. Differences in clinical outcomes, health care resource utilization and costs in heart failure patients according to left ventricular ejection fraction
  5. Sex-specific presentation, care, and clinical events in individuals admitted with NSTEMI: the ACVC-EAPCI EORP NSTEMI registry of the European Society of Cardiology
  6. Secondary prevention therapies in real-world patients with myocardial infarction: eligibility based on randomized trials supporting European and American guidelines
  7. Impact of standard modifiable cardiovascular risk factors on 2-year all-cause mortality: Insights from an international cohort of 23,489 patients with acute coronary syndrome
  8. Sex‐Specific Associations of Obstructive Sleep Apnea Risk With Patient Characteristics and Functional Outcomes After Acute Myocardial Infarction: Evidence From the VIRGO Study
  9. Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis
  10. Acetazolamide for acute heart failure: is ADVOR a riddle wrapped in a mystery inside an enigma?
  11. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
  12. Sex differences in patterns of referral and resource utilization in the cardiology clinic: an outpatient analysis
  13. Una imagen PET amiloide estática del primer minuto (FMF) se correlaciona con [18F]FDG PET en pacientes con afasia progresiva primaria
  14. Static first-minute-frame (FMF) PET imaging after 18F-labeled amyloid tracer injection is correlated to [18F]FDG PET in patients with primary progressive aphasia
  15. Pronóstico a largo plazo de la extensión de la TAPD en una cohorte consecutiva de pacientes con IAMCEST
  16. Long-term outcomes of extended DAPT in a real-life cohort of consecutive STEMI patients
  17. Evolución de la asistencia cardiovascular en el Sistema Nacional de Salud de España. Datos del proyecto RECALCAR 2011-2020
  18. Trends in cardiovascular care in the National Health System in Spain. Data from the RECALCAR project 2011-2020
  19. Subclinical atherosclerosis and accelerated epigenetic age mediated by inflammation: a multi-omics study
  20. Ivabradine for controlling heart rate in permanent atrial fibrillation: A translational clinical trial
  21. ECMO in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension as a bridge to therapy
  22. Effect of Routine Invasive vs Conservative Strategy in Older Adults With Frailty and Non–ST-Segment Elevation Acute Myocardial Infarction
  23. Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology
  24. External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued ...
  25. Epidemiología de las enfermedades valvulares aórticas no reumáticas en España, 2003-2018
  26. CD69 expression on regulatory T cells protects from immune damage after myocardial infarction
  27. Cohort Profile: The ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry
  28. A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction
  29. Polypill Strategy in Secondary Cardiovascular Prevention
  30. A visual and innovative representation of the clinical trajectory of patients after an acute exacerbation of COPD. Results of the COHERENT-COPD study
  31. Estimation and visual representation of hospital costs after an acute exacerbation of COPD. COHERENT-COPD study.
  32. Mortality according to age, sex, or congestive heart failure after an acute COPD exacerbation. COHERENT-COPD study.
  33. CASSIA (cardiology software suite for image analysis): a potential new tool for the evaluation of [18F]FDG PET/CT in the setting of infective endocarditis
  34. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
  35. Interaction between VA-ECMO and the right ventricle
  36. ¿Podemos mejorar la atención a la insuficiencia cardiaca en España?
  37. The Clinical outcomes, healthcare resource utilization, and related costs (COHERENT) model. Application in heart failure patients
  38. Positive psychology differences and risk stratification between STEMI and NSTEMI
  39. El modelo Clinical outcomes, healthcare resource utilization, and related costs (COHERENT). Aplicación en pacientes con insuficiencia cardiaca
  40. Time trends in the epidemiology of nonrheumatic aortic valve disease in Spain, 2003-2018
  41. Comments on the 2021 ESC/EACTS guidelines for the management of valvular heart disease
  42. Corrigendum to “Diagnosis, prevention, and management of delirium in the intensive cardiac care unit” [Am Heart J. 2021 Feb;232:164-176]
  43. Depression and Perceived Stress After Spontaneous Coronary Artery Dissection and Comparison With Other Acute Myocardial Infarction (the VIRGO Experience)
  44. New 3-Dimensional Volumetric Ultrasound Method for Accurate Quantification of Atherosclerotic Plaque Volume
  45. Comments on the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
  46. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribu...
  47. State of the STEMI Care Network after the early phase of the COVID-19 pandemic. The experience of a high-volume centre
  48. Sex differences in temporal trends in main and secondary pulmonary embolism diagnosis and case fatality rates: 2003–2019
  49. Comments on the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice
  50. Comments on the 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy
  51. Las diferencias por sexo en la mortalidad tras un síndrome coronario agudo se incrementan en los países de menor riqueza y mayor desigualdad de ingresos
  52. Cost–effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial
  53. Early vs. Delayed Initiation of Treatment With P2Y12 Inhibitors in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
  54. Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19
  55. Health status outcomes after spontaneous coronary artery dissection and comparison with other acute myocardial infarction: The VIRGO experience
  56. Primary vs. Secondary Heart Failure Diagnosis: Differences in Clinical Outcomes, Healthcare Resource Utilization and Cost
  57. Bone marrow activation in response to metabolic syndrome and early atherosclerosis
  58. Circadian rhythms in thrombosis and atherothrombotic events
  59. A systematic review and meta-analysis of randomized controlled trials evaluating pharmacologic therapies for acute and recurrent pericarditis
  60. Efficacy of psychological interventions on clinical outcomes of coronary artery disease: Systematic review and meta-analysis
  61. Managing end of life in intensive cardiac care units
  62. The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23
  63. Acute Heart Failure in the 2021 ESC Heart Failure Guidelines: a scientific statement from the Association for Acute CardioVascular Care (ACVC) of the European Society of Cardiology
  64. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up
  65. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis
  66. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis
  67. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up
  68. Angiotensin Receptor–Neprilysin Inhibition in Acute Myocardial Infarction
  69. Impact of sex differences and network systems on the in-hospital mortality of patients with ST-segment elevation acute myocardial infarction
  70. Impacto de las diferencias de sexo y los sistemas de red en la mortalidad hospitalaria de pacientes con infarto agudo de miocardio con elevación del segmento ST
  71. An image processing tool for the detection of anthracycline-induced cardiotoxicity by evaluating the myocardial metabolic activity in [18F]FDG PET/CT
  72. Variations in Quality of Care by Sex and Social Determinants of Health Among Younger Adults With Acute Myocardial Infarction in the US and Canada
  73. Electrocardiogram Changes in the Spectrum of TTNtv Dilated Cardiomyopathy: Accuracy and Predictive Value of a New Index for LV-Changes Identification
  74. PRospective Evaluation of natriuretic peptide-based reFERral of patients with chronic heart failure in primary care (PREFER): a real-world study
  75. Sex Differences in Chronic Thromboembolic Pulmonary Hypertension. Treatment Options over Time in a National Referral Center
  76. Requirements and sustainability of primary PCI programs in Spain for the management of patients with STEMI. SEC, AEEC, and SEMES consensus document
  77. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)
  78. First experience of percutaneous Bi-Pella in Spain
  79. Primera experiencia con Bi-Pella percutáneo en España
  80. High Correlation of Static First-Minute-Frame (FMF) PET Imaging after 18F-Labeled Amyloid Tracer Injection with [18F]FDG PET Imaging
  81. In-hospital outcomes of mechanical complications in acute myocardial infarction: Analysis from a nationwide Spanish database
  82. Outcome of patients with different clinical presentations of high-risk pulmonary embolism
  83. Efficacy and Safety of Colchicine in Post–acute Myocardial Infarction Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
  84. Thirteen‐year trends in hospitalization and outcomes of patients with heart failure in Spain
  85. Glycated Hemoglobin and Subclinical Atherosclerosis in People Without Diabetes
  86. Sex differences in mortality after an acute coronary syndrome increase with lower country wealth and higher income inequality
  87. Triglycerides and Residual Atherosclerotic Risk
  88. Comments on the 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
  89. Comments on the 2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease
  90. A Novel Circulating MicroRNA for the Detection of Acute Myocarditis
  91. Diabetes-Related Factors and the Effects of Ticagrelor Plus Aspirin in the THEMIS and THEMIS-PCI Trials
  92. Comments on the 2020 ESC guidelines for the management of adult congenital heart disease
  93. Comments on the 2020 ESC/EACTS guidelines for the management of atrial fibrillation
  94. Comentarios a la guía ESC/EACTS 2020 sobre el diagnóstico y tratamiento de la fibrilación auricular
  95. The year in cardiovascular medicine 2020: heart failure and cardiomyopathies
  96. Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study
  97. Venous lactate improves the prediction of in-hospital adverse outcomes in normotensive pulmonary embolism
  98. Impacto clínico, psicológico, formativo y profesional de la pandemia de COVID-19 en jóvenes cardiólogos españoles
  99. Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study
  100. Baseline CHA 2 DS 2 ‐VASc score and prognosis in octogenarians with non‐ST segment elevation acute coronary syndrome
  101. Contemporary economic burden in a real‐world heart failure population with Commercial and Medicare supplemental plans
  102. Sex bias in admission to tertiary‐care centres for acute myocardial infarction and cardiogenic shock
  103. Synergistic Impact of Systolic Blood Pressure and Perfusion Status on Mortality in Acute Heart Failure
  104. Impact of frailty and atrial fibrillation in elderly patients with acute coronary syndromes
  105. Corrigendum to: The year in cardiovascular medicine 2020: heart failure and cardiomyopathies
  106. Long-Term Antithrombotic Therapy and Clinical Outcomes in Patients with Acute Coronary Syndrome and Renal Impairment: Insights from EPICOR and EPICOR Asia
  107. Effects of a Novel Nitroxyl Donor in Acute Heart Failure
  108. The 2020 ESC-ACVC quality indicators for the management of acute myocardial infarction applied to the FAST-MI registries
  109. 2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group
  110. Diagnosis, prevention, and management of delirium in the intensive cardiac care unit
  111. Composition, structure, and function of heart teams: a joint position paper of the ACVC, EAPCI, EACTS, and EACTA focused on the management of patients with complex coronary artery disease requiring myocardial revascularization
  112. Number of Antithrombotic Drugs Used Early and In-hospital Outcomes in Acute Coronary Syndromes
  113. The year in cardiovascular medicine 2020: heart failure and cardiomyopathies
  114. Composition, structure, and function of heart teams: a joint position paper of the ACVC, EAPCI, EACTS, and EACTA focused on the management of patients with complex coronary artery disease requiring myocardial revascularization
  115. Unidad de dolor torácico: no olvidar los índices clínicos
  116. Unidad de dolor torácico: no olvidar los índices clínicos. Respuesta
  117. Chest pain unit: do not forget the clinical indexes
  118. Incidence and outcomes of hospital treated acute myocarditis from 2003 to 2015 in Spain
  119. Corrigendum to ‘Departments involved during the first episode of acute heart failure and analysis of emergency department revisits and rehospitalisations: an outlook through the NOVICA cohort’ [Eur J Heart Fail 2019;21:1231–1244]
  120. Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis
  121. New three-dimensional volumetric ultrasound probe for accurate quantification of atherosclerotic plaque volume
  122. Newly diagnosed diabetes and outcomes after acute myocardial infarction in young adults
  123. A Network of Macrophages Supports Mitochondrial Homeostasis in the Heart
  124. Aging-Associated miR-217 Aggravates Atherosclerosis and Promotes Cardiovascular Dysfunction
  125. Machine Learning Improves Cardiovascular Risk Definition for Young, Asymptomatic Individuals
  126. Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: a single-center retrospective study
  127. Association Between Body Size Phenotypes and Subclinical Atherosclerosis
  128. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
  129. Automatic Diagnosis of Chronic Thromboembolic Pulmonary Hypertension Based on Volumetric Data from SPECT Ventilation and Perfusion Images
  130. Risk stratification scores for patients with acute heart failure in the Emergency Department: A systematic review
  131. Tocilizumab for the treatment of adult patients with severe COVID‐19 pneumonia: A single‐center cohort study
  132. MEESSI-AHF risk score performance to predict multiple post-index event and post-discharge short-term outcomes
  133. Has the Fourth Universal Definition of Myocardial Infarction led to better diagnosis and risk stratification?
  134. Decreased salivary lactoferrin levels are specific to Alzheimer's disease
  135. Tendencias en el tratamiento del shock cardiogénico e impacto pronóstico del tipo de centros tratantes
  136. 403-P: Impact of Diabetes-Related Factors and Background Antihyperglycemic Therapy on the Efficacy and Safety of Ticagrelor Added to Aspirin: Insights from the THEMIS Trial
  137. Comments on the 2019 ESC guidelines on chronic coronary syndromes
  138. Comments on the 2019 ESC guidelines on acute pulmonary embolism
  139. Comments on the 2019 ESC guidelines on supraventricular tachycardia
  140. Comentarios a la guía ESC 2019 sobre embolia pulmonar aguda
  141. Comentarios a la guía ESC 2019 sobre taquicardia supraventricular
  142. Guía ESC 2019 para el diagnóstico y tratamiento de la embolia pulmonar aguda
  143. Guía ESC 2019 sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes (EASD)
  144. Corrección en el artículo de Galian-Gay et al. «Determinantes del resultado a largo plazo de la estenosis de válvula pulmonar reparada», Rev Esp Cardiol. 2020;73:131-138
  145. Comentarios a la guía ESC/EAS 2019 sobre el tratamiento de las dislipemias
  146. Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high‐risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology
  147. Efficacy of psychological interventions on psychological outcomes in coronary artery disease: systematic review and meta-analysis
  148. Decreased salivary lactoferrin levels are specific to Alzheimer’s disease
  149. Short-Term Progression of Multiterritorial Subclinical Atherosclerosis
  150. Assessment of quality indicators for acute myocardial infarction management in 28 countries and use of composite quality indicators for benchmarking
  151. Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of C...
  152. Comments on the 2019 ESC guidelines on diabetes, prediabetes, and cardiovascular disease
  153. Comments on the 2019 ESC/EAS guidelines for the management of dyslipidemias
  154. Atrial fibrillation in acute heart failure: A position statement from the Acute Cardiovascular Care Association and European Heart Rhythm Association of the European Society of Cardiology
  155. Diagnosis and risk stratification of chest pain patients in the emergency department: focus on acute coronary syndromes. A position paper of the Acute Cardiovascular Care Association
  156. Prognostic impact of anemia according to frailty status in elderly patients with acute coronary syndromes
  157. Posicionamientos de la Sociedad Española de Cardiología sobre procesos y procedimientos cardiológicos en la pandemia de COVID-19
  158. Long-Term Outcome of Acute Coronary Syndromes in Patients on Chronic Oral Anticoagulants: Data from the EPICOR Study
  159. Trends in cardiogenic shock management and prognostic impact of type of treating center
  160. Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial
  161. Meta-Analysis Design and Results in Real Life: Problem Solvers or Detour to Maze. A Critical Review of Meta-Analysis of DAPT Randomized Controlled Trials
  162. Quantitative Analysis of Brain 18F-fluordesoxyglucose and Early-Phase 18F-florbetapir Positron Emission Tomography
  163. Ticagrelor in Patients with Stable Coronary Disease and Diabetes
  164. In-Hospital Coronary Revascularization Rates and Post-Discharge Mortality Risk in Non–ST-Segment Elevation Acute Coronary Syndrome
  165. Impacto de la FRAgilidad y otros síndromes Geriátricos en el manejo clínico y pronóstico del paciente anciano ambulatorio con Insuficiencia Cardiaca (FRAGIC). Estudio prospectivo y multicéntrico
  166. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial
  167. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
  168. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
  169. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
  170. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
  171. Departments involved during the first episode of acute heart failure and subsequent emergency department revisits and rehospitalisations: an outlook through the NOVICA cohort
  172. Influence of the length of hospitalisation in post-discharge outcomes in patients with acute heart failure: Results of the LOHRCA study
  173. Cardiologists and the Cardiology of the Future. Vision and proposals of the Spanish Society of Cardiology for the Cardiology of the 21st Century
  174. Percutaneous cardiological intervention and cardiac surgery: patient-centered care. Position statement of the Spanish Society of Cardiology
  175. Analysis of How Emergency Physicians’ Decisions to Hospitalize or Discharge Patients With Acute Heart Failure Match the Clinical Risk Categories of the MEESSI-AHF Scale
  176. El Cardiólogo y la Cardiología del Futuro: visión y propuestas de la Sociedad Española de Cardiología para la cardiología del siglo XXI
  177. Most elderly patients hospitalized for heart failure lack the abilities needed to perform the tasks required for self‐care: impact on outcomes
  178. Intervencionismo percutáneo cardiológico y cirugía cardiaca: el paciente en el centro de los procesos. Documento de posicionamiento de la Sociedad Española de Cardiología
  179. Safe and Efficacious Use of 1-Month Triple Therapy in Patients with Atrial Fibrillation and High Bleeding Risk Undergoing PCI
  180. Global Rounds
  181. Corrigendum to: 2018 ESC/EACTS Guidelines on myocardial revascularization
  182. Does Socioeconomic Status Influence the Risk of Subclinical Atherosclerosis?
  183. Effect of risk of malnutrition on 30-day mortality among older patients with acute heart failure in Emergency Departments
  184. Expert consensus document: Reporting checklist for quantification of pulmonary congestion by lung ultrasound in heart failure
  185. Effect of Barthel Index on the Risk of Thirty-Day Mortality in Patients With Acute Heart Failure Attending the Emergency Department: A Cohort Study of Nine Thousand Ninety-Eight Patients From the Epidemiology of Acute Heart Failure in Emergency Departm...
  186. Worse 12-month prognosis in women with non-valvular atrial fibrillation undergoing percutaneous coronary intervention
  187. Evaluation of a nurse-led intervention program in heart failure: A randomized trial
  188. Revascularisation in older adult patients with non-ST-segment elevation acute coronary syndrome: effect and impact on 6-month mortality
  189. Mitral Regurgitation and Prognosis After Non‐ST‐Segment Elevation Myocardial Infarction in Very Old Patients
  190. Safety of drug-eluting stents compared to bare metal stents in patients with an indication for long-term oral anticoagulation: A propensity score matched analysis
  191. Comorbidity assessment for mortality risk stratification in elderly patients with acute coronary syndrome
  192. Vascular Inflammation in Subclinical Atherosclerosis Detected by Hybrid PET/MRI
  193. Utilidad de la escala MEESSI para la estratificación del riesgo de pacientes con insuficiencia cardiaca aguda en servicios de urgencias
  194. The Usefulness of the MEESSI Score for Risk Stratification of Patients With Acute Heart Failure at the Emergency Department
  195. EFFICACY OF COGNITIVE BEHAVIORAL THERAPY AND POSITIVE PSYCHOLOGY ON PSYCHOLOGICAL OUTCOMES IN PATIENTS WITH CORONARY ARTERY DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS
  196. 2018 ESC/ESH Guidelines for the management of arterial hypertension
  197. Rationale, Design, and Baseline Characteristics of THEMIS: Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study
  198. Comments on the 2018 ESC Guidelines for the Management of Cardiovascular Diseases During Pregnancy
  199. Comments on the 2018 ESC/ESH Guidelines for the Management of Arterial Hypertension
  200. Invasive Versus Conservative Strategy in Frail Patients With NSTEMI: The MOSCA-FRAIL Clinical Trial Study Design
  201. Estrategia invasiva frente a conservadora en pacientes frágiles con IAMSEST. Diseño del ensayo clínico MOSCA-FRAIL
  202. Comentarios a la guía ESC/ESH 2018 sobre el diagnóstico y tratamiento de la hipertensión arterial
  203. 2018 ESC/EACTS Guidelines on myocardial revascularization
  204. Comentarios a la guía ESC 2018 sobre el tratamiento de las enfermedades cardiovasculares durante el embarazo
  205. Diabetes mellitus, frailty and prognosis in very elderly patients with acute coronary syndromes
  206. Fibroblast growth factor-23 promotes rhythm alterations and contractile dysfunction in adult ventricular cardiomyocytes
  207. Statin Treatment and Prognosis of Elderly Patients Discharged after Non-ST Segment Elevation Acute Coronary Syndrome
  208. Association of Sleep Duration and Quality With Subclinical Atherosclerosis
  209. Comments on the 2018 ESC Fourth Universal Definition of Myocardial Infarction
  210. Comments on the 2018 ESC/EACTS Guidelines for Myocardial Revascularization
  211. Recommendations of the Geriatric Cardiology Section of the Spanish Society of Cardiology for the Assessment of Frailty in Elderly Patients With Heart Disease
  212. Recomendaciones de la Sección de Cardiología Geriátrica de la Sociedad Española de Cardiología para la valoración de la fragilidad en el anciano con cardiopatía
  213. Comentarios al consenso ESC 2018 sobre la cuarta definición universal del infarto de miocardio
  214. 2018 ESC/EACTS Guidelines on myocardial revascularization
  215. Fourth universal definition of myocardial infarction (2018)
  216. Predictors of all‐cause mortality and ischemic events within and beyond 1 year after an acute coronary syndrome: Results from the EPICOR registry
  217. Impact of Frailty on Mortality and Hospitalization in Chronic Heart Failure: A Systematic Review and Meta‐Analysis
  218. Anticoagulación en el anciano: ¿son suficientes guías y algoritmos para ejercer bien la medicina o todavía queda lugar para el arte?
  219. The microRNA-29/PGC1α regulatory axis is critical for metabolic control of cardiac function
  220. Comments on the 2018 ESC Guidelines for the Diagnosis and Management of Syncope
  221. Comentarios a la guía ESC 2018 sobre el diagnóstico y el tratamiento del síncope
  222. 2017 ESC GUIDELINES ON THE DIAGNOSIS AND TREATMENT OF PERIPHERAL ARTERIAL DISEASES, IN COLLABORATION WITH THE EUROPEAN SOCIETY FOR VASCULAR SURGERY (ESVS)
  223. Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarction
  224. Octogenarian women with acute coronary syndrome present frailty and readmissions more frequently than men
  225. 2018 ESC/EACTS Guidelines on myocardial revascularization
  226. 2018 ESC/ESH Guidelines for the management of arterial hypertension
  227. 2018 ESC/EACTS Guidelines on myocardial revascularization
  228. Fourth universal definition of myocardial infarction (2018)
  229. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
  230. Temporal Trends in Mechanical Complications of Acute Myocardial Infarction in the Elderly
  231. 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the Eu...
  232. Hands-on training in acute cardiac care
  233. Presentation, Clinical Profile, and Prognosis of Young Patients With Myocardial Infarction With Nonobstructive Coronary Arteries (MINOCA): Results From the VIRGO Study
  234. Invasive strategy and frailty in very elderly patients with acute coronary syndromes
  235. Integrating the results of the CULPRIT-SHOCK trial in the 2017 ESC ST-elevation myocardial infarction guidelines: viewpoint of the task force
  236. Time trends in characteristics, clinical course, and outcomes of 13,791 patients with acute heart failure
  237. Zika virus selectively kills aggressive human embryonal CNS tumor cells in vitro and in vivo
  238. Early to bed and early to rise makes a patient healthy, a hospital wealthy, and a doctor wise, or not?
  239. Regional variations in hospital management and post-discharge mortality in patients with non-ST-segment elevation acute coronary syndrome
  240. Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry
  241. An Easy Assessment of Frailty at Baseline Independently Predicts Prognosis in Very Elderly Patients With Acute Coronary Syndromes
  242. Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society...
  243. Sex Differences in Timeliness of Reperfusion in Young Patients With ST‐Segment–Elevation Myocardial Infarction by Initial Electrocardiographic Characteristics
  244. 2018 ESC Guidelines for the diagnosis and management of syncope
  245. Practical Instructions for the 2018 ESC Guidelines for the diagnosis and management of syncope
  246. Acute heart failure: lessons learned, roads ahead
  247. Optimised care of elderly patients with acute coronary syndrome
  248. Editor's Choice – 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
  249. The future of continuing medical education: the roles of medical professional societies and the health care industry
  250. European Society of Cardiology, acute cardiovascular care association, SCAD study group: a position paper on spontaneous coronary artery dissection
  251. Editor’s Choice - Frailty and the management of patients with acute cardiovascular disease: A position paper from the Acute Cardiovascular Care Association
  252. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
  253. Correction
  254. Variable Expressivity of a Founder Mutation in the EIF2AK4 Gene in Hereditary Pulmonary Veno-occlusive Disease and Its Impact on Survival
  255. Guía ESC 2017 sobre el diagnóstico y tratamiento de la enfermedad arterial periférica, desarrollada en colaboración con la European Society for Vascular Surgery (ESVS)
  256. Guía ESC/EACTS 2017 sobre el tratamiento de las valvulopatías
  257. Global Geriatric Assessment and In-Hospital Bleeding Risk in Elderly Patients with Acute Coronary Syndromes: Insights from the LONGEVO-SCA Registry
  258. Expresividad variable de una mutación fundadora en el gen EIF2AK4 en pacientes con enfermedad venooclusiva pulmonar hereditaria. Impacto en la supervivencia
  259. Special article 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
  260. Actualización ESC 2017 sobre el tratamiento antiagregante plaquetario doble en la enfermedad coronaria, desarrollada en colaboración con la EACTS
  261. Uaktualnione stanowisko ESC dotyczące stosowania podwójnej terapii przeciwpłytkowej w chorobie wieńcowej w 2017 roku, przygotowane we współpracy z EACTS
  262. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
  263. Acute heart failure after STEMI. Still a problem, still an opportunity for improving care quality
  264. Comments on the 2017 ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-segment Elevation
  265. Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors
  266. Guía ESC 2017 sobre el tratamiento del infarto agudo de miocardio en pacientes con elevación del segmento ST
  267. Comentarios a la guía ESC 2017 sobre el tratamiento del infarto agudo de miocardio en pacientes con elevación del segmento ST
  268. Indications and practical approach to non-invasive ventilation in acute heart failure
  269. Comparison of Electrocardiographic Characteristics in Men Versus Women ≤ 55 Years With Acute Myocardial Infarction (a Variation in Recovery: Role of Gender on Outcomes of Young Acute Myocardial Infarction Patients Substudy)
  270. Initiatives to Achieve Excellence in the Care of Acute Coronary Syndrome. Response
  271. Predicting Subclinical Atherosclerosis in Low-Risk Individuals
  272. Iniciativas para conseguir una atención excelente en el síndrome coronario agudo. Respuesta
  273. Corrigendum
  274. Corrigendum to: 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
  275. Predicting 30-Day Mortality for Patients With Acute Heart Failure in the Emergency Department
  276. The Importance of Breakfast in Atherosclerosis Disease
  277. Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality
  278. Impact of Frailty and Disability on 30-Day Mortality in Older Patients With Acute Heart Failure
  279. Clinical and Economic Impact of a Multisciplinary Intervention to Reduce Bleeding Risk in Patients With Acute Coronary Syndrome
  280. Relación entre las situaciones clínicas que llevan al tratamiento exclusivamente farmacológico del SCASEST y su pronóstico
  281. Análisis de los resultados económicos y en salud de un programa dirigido a la reducción de hemorragia en pacientes con síndrome coronario agudo
  282. Immunoglobulin therapy modulates the severe inflammatory progression of neuromuscular disorders
  283. Corrigendum to ‘2017 ESC/EACTS Guidelines for the management of valvular heart disease’ [Eur J Cardiothorac Surg 2017;52:616-664]†
  284. Characteristics and outcomes of medically managed patients with non-ST-segment elevation acute coronary syndromes: Insights from the multinational EPICOR Asia study
  285. Sudden Cardiac Death in Professional Soccer Players
  286. Case-based implementation of the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease†
  287. Questions and answers on diagnosis and management of patients with Peripheral Arterial Diseases: a companion document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Societ...
  288. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
  289. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
  290. 2017 ESC/EACTS Guidelines for the management of valvular heart disease
  291. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
  292. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
  293. 2017 ESC/EACTS Guidelines for the management of valvular heart disease
  294. Editor’s Choice - Acute Cardiovascular Care Association Position Paper on Intensive Cardiovascular Care Units: An update on their definition, structure, organisation and function
  295. Predicting two-year mortality from discharge after acute coronary syndrome: An internationally-based risk score
  296. Planning secondary prevention: Room for improvement
  297. Role of the polypill for secondary prevention in ischaemic heart disease
  298. Assessment of Quality Indicators for Acute Myocardial Infarction in the FAST-MI (French Registry of Acute ST-Elevation or Non–ST-Elevation Myocardial Infarction) Registries
  299. β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction
  300. Sexual Activity and Function in the Year After an Acute Myocardial Infarction Among Younger Women and Men in the United States and Spain
  301. Depression Treatment and Health Status Outcomes in Young Patients With Acute Myocardial Infarction
  302. Expert consensus document: Echocardiography and lung ultrasonography for the assessment and management of acute heart failure
  303. Challenges in secondary prevention after acute myocardial infarction: A call for action
  304. Extended dual antiplatelet therapy after acute coronary syndrome in Spain: Results from the EPICOR study
  305. Challenges in secondary prevention after acute myocardial infarction: A call for action
  306. Association Between Clinical Pathways Leading to Medical Management and Prognosis in Patients With NSTEACS
  307. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
  308. Predictive capacity of a multimarker strategy to determine short-term mortality in patients attending a hospital emergency Department for acute heart failure. BIO-EAHFE study
  309. IMPACT OF A SWITCH FROM DUAL ANTIPLATELET THERAPY TO SINGLE ANTIPLATELET THERAPY IN DIABETES AND NON-DIABETES POST ACS: INSIGHTS FROM THE EPICOR AND EPICOR-ASIA STUDIES
  310. PREDICTIVE VALUES OF THE IDEAL CARDIOVASCULAR HEALTH AND THE FUSTER-BEWAT SCORES FOR DETECTING SUBCLINICAL ATHEROSCLEROSIS IN HEALTHY INDIVIDUALS
  311. PREDICTORS OF ISCHEMIC EVENTS WITHIN AND AFTER 1 YEAR AFTER AN ACUTE CORONARY SYNDROME: RESULTS FROM THE EPICOR REGISTRY
  312. Performance of hospitals according to the ESC ACCA quality indicators and 30-day mortality for acute myocardial infarction: national cohort study using the United Kingdom Myocardial Ischaemia National Audit Project (MINAP) register
  313. Myocardial injury in severe heritable pulmonary veno-occlusive disease
  314. Editor’s Choice-The organization of chest pain units: Position statement of the Acute Cardiovascular Care Association
  315. Sex differences in lipid profiles and treatment utilization among young adults with acute myocardial infarction: Results from the VIRGO study
  316. Perceived Stress After Acute Myocardial Infarction
  317. 2016 ESC GUIDELINES FOR THE MANAGEMENT OF ATRIAL FIBRILLATION DEVELOPEDIN COLLABORATION WITH EACTS
  318. Platelet Inhibition as a Therapeutic Approach in Intravascular Intervention
  319. Erratum
  320. Oxidized LDL is Associated with Metabolic Syndrome Traits Independently of Central Obesity and Insulin Resistance
  321. 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
  322. Comments on the 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
  323. Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
  324. Comentarios a la guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
  325. Gender differences in physical activity following acute myocardial infarction in adults: A prospective, observational study
  326. No evidence of adverse cardiac remodeling in former elite endurance athletes
  327. Practical approach on frail older patients attended for acute heart failure
  328. Wytyczne ESC dotyczące diagnostyki i leczenia ostrej i przewlekłej niewydolności serca w 2016 roku
  329. Effect of diastolic dysfunction on postoperative outcomes after cardiovascular surgery: A systematic review and meta-analysis
  330. Sexual Activity and Function in the Year After an Acute Myocardial Infarction Among Younger Women and Men in the United States and Spain
  331. Guía ESC 2016 sobre prevención de la enfermedad cardiovascular en la práctica clínica
  332. European Society of Cardiology-Acute Cardiovascular Care Association Position paper on acute heart failure: A call for interdisciplinary care
  333. Quality indicators for acute myocardial infarction: A position paper of the Acute Cardiovascular Care Association
  334. Association of Clinical Factors and Therapeutic Strategies With Improvements in Survival Following Non–ST-Elevation Myocardial Infarction, 2003-2013
  335. Challenges in secondary prevention after acute myocardial infarction: A call for action
  336. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
  337. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
  338. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
  339. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
  340. International patterns of dual antiplatelet therapy duration after acute coronary syndromes
  341. Editor’s Choice-Sex differences in young patients with acute myocardial infarction: A VIRGO study analysis
  342. Management of Acute Coronary Syndromes in Geriatric Patients
  343. Association Between a Social-Business Eating Pattern and Early Asymptomatic Atherosclerosis
  344. Contemporary roles of registries in clinical cardiology: Insights from Western and Eastern European countries
  345. BETAWIN-AHF study: effect of beta-blocker withdrawal during acute decompensation in patients with chronic heart failure
  346. Heart failure: health is priceless… but still expensive
  347. Impact of Frailty and Other Geriatric Syndromes on Clinical Management and Outcomes in Elderly Patients With Non-ST-Segment Elevation Acute Coronary Syndromes: Rationale and Design of the LONGEVO-SCA Registry
  348. Report of the European Society of Cardiology Cardiovascular Round Table regulatory workshop update of the evaluation of new agents for the treatment of acute coronary syndrome: Executive summary
  349. 2016 European Guidelines on cardiovascular disease prevention in clinical practice
  350. The race for higher sensitivity troponins, but for what prize?
  351. Evaluación de los conocimientos y la percepción de soporte a la enfermedad en los pacientes con insuficiencia cardiaca. Estudio SOPICA EN ESPAÑA
  352. Trends in heart failure: going in the right direction?
  353. 2016 European Guidelines on cardiovascular disease prevention in clinical practice
  354. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
  355. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
  356. Tiempo de estancia prolongado en los pacientes ingresados por insuficiencia cardiaca aguda
  357. Disposition of emergency department patients diagnosed with acute heart failure
  358. Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure
  359. Tako-tsubo cardiomyopathy triggered by multiple shocks in electrical storm
  360. Trends in Risk Factors and Treatments in Patients With Stable Ischemic Heart Disease Seen at Cardiology Clinics Between 2006 and 2014
  361. Tendencias en factores de riesgo y tratamientos de pacientes con cardiopatía isquémica estable atendidos en consultas de cardiología entre 2006 y 2014
  362. Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology
  363. European Society of Cardiology – Acute Cardiovascular Care Association position paper on safe discharge of acute heart failure patients from the emergency department
  364. Prehospital and in-hospital use of healthcare resources in patients surviving acute coronary syndromes: an analysis of the EPICOR registry
  365. Return to Work After Acute Myocardial Infarction
  366. Guía ESC/ERS 2015 sobre diagnóstico y tratamiento de la hipertensión pulmonar
  367. Guía ESC 2015 sobre el tratamiento de pacientes con arritmiasventriculares y prevención de la muerte súbita cardiaca
  368. Impact of Triple Therapy in Elderly Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
  369. Riesgo cardiovascular a largo plazo tras un síndrome coronario agudo, todavía un reto
  370. Long-term Cardiovascular Risk After Acute Coronary Syndrome, An Ongoing Challenge
  371. Effects of Triple Therapy in Patients With Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Regarding Thromboembolic Risk Stratification
  372. Guía ESC 2015 sobre el tratamiento de la endocarditis infecciosa
  373. Acute Heart Failure
  374. Optimisation of antithrombotic therapy in patients with acute coronary syndrome to reduce bleeding episodes
  375. Guía ESC 2015 sobre el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST
  376. The cardiovascular polypill: clinical data and ongoing studies
  377. Insurance and Prehospital Delay in Patients ≤55 Years With Acute Myocardial Infarction
  378. Comments on the 2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation
  379. Artículo especial Guía ESC 2015 sobre el diagnóstico y tratamiento de las enfermedades del pericardio
  380. Incidence and impact of delirium on clinical and functional outcomes in older patients hospitalized for acute cardiac diseases
  381. Sex Differences in Cardiac Risk Factors, Perceived Risk, and Health Care Provider Discussion of Risk and Risk Modification Among Young Patients With Acute Myocardial Infarction
  382. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
  383. Time trends in coronary revascularization procedures among people with COPD: analysis of the Spanish national hospital discharge data (2001–2011)
  384. The Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients (VIRGO) Classification SystemCLINICAL PERSPECTIVE
  385. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
  386. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
  387. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases
  388. 2015 ESC Guidelines for the management of infective endocarditis
  389. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
  390. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
  391. Pre-hospital management of patients with chest pain and/or dyspnoea of cardiac origin. A position paper of the Acute Cardiovascular Care Association (ACCA) of the ESC.
  392. Editor’s Choice-The role of the emergency department in the management of acute heart failure: An international perspective on education and research
  393. CardioPulse Articles * The National Cardiac Societies of the European Society of Cardiology * Cardiology update 2015: a tradition in excellent postgraduate education supported by the European Society of Cardiology * Sir Donald Ross, pioneer aortic valv...
  394. How does a clinical trial fit into the real world? The RELAX-AHF study population into the EAHFE registry
  395. Gender Differences in the Trajectory of Recovery in Health Status Among Young Patients With Acute Myocardial Infarction: Results From the Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients (VIRGO) Study
  396. Depressive Symptoms in Younger Women and Men With Acute Myocardial Infarction: Insights From the VIRGO Study
  397. Medical management: the dark side of acute coronary syndromes
  398. IMPACT OF DELIRIUM ON CLINICAL AND FUNCTIONAL OUTCOMES IN OLDER PATIENTS HOSPITALIZED FOR AN ACUTE CARDIAC DISEASE
  399. LONG-TERM CARDIOVASCULAR OUTCOMES IN A REAL-LIFE COHORT OF CONTEMPORARY MYOCARDIAL INFARCTION PATIENTS FREE OF EVENTS AT 1 YEAR: A SUBANALYSIS OF THE EPICOR STUDY
  400. IMPACT OF DIASTOLIC DYSFUNCTION ON POST-OPERATIVE OUTCOMES AFTER CARDIAC SURGERY: A META-ANALYSIS
  401. CHARACTERISTICS AND OUTCOMES OF MEDICALLY MANAGED PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES: INSIGHTS FROM THE MULTINATIONAL EPICOR ASIA STUDY
  402. SEX DIFFERENCES IN 12-MONTH HEALTH STATUS IN YOUNG PATIENTS FOLLOWING ACUTE MYOCARDIAL INFARCTION: RESULTS FROM THE VIRGO STUDY (VARIATION IN RECOVERY: ROLE OF GENDER ON OUTCOMES OF YOUNG ACUTE MYOCARDIAL INFARCTION PATIENTS)
  403. Gender differences in pre-event health status of young patients with acute myocardial infarction: A VIRGO study analysis
  404. Sex Differences in Perceived Stress and Early Recovery in Young and Middle-Aged Patients With Acute Myocardial Infarction
  405. Non-ST-segment elevation acute coronary syndromes
  406. The use of echocardiography in acute cardiovascular care: Recommendations of the European Association of Cardiovascular Imaging and the Acute Cardiovascular Care Association
  407. Opportunities for improvement in anti-thrombotic therapy and other strategies for the management of acute coronary syndromes: Insights from EPICOR, an international study of current practice patterns
  408. Temporal trends in the use of reperfusion therapy and outcomes in elderly patients with first ST elevation myocardial infarction
  409. Sexual Activity and Counseling in the First Month After Acute Myocardial Infarction Among Younger Adults in the United States and Spain: A Prospective, Observational Study
  410. FRAIL-HF, a Study to Evaluate the Clinical Complexity of Heart Failure in Nondependent Older Patients: Rationale, Methods and Baseline Characteristics
  411. Grupo de Trabajo Conjunto sobre cirugía no cardiaca: Evaluación y manejo cardiovascular de la Sociedad Europea de Cardiología (ESC) y la European Society of Anesthesiology (ESA)
  412. The use of echocardiography in acute cardiovascular care: Recommendations of the European Association of Cardiovascular Imaging and the Acute Cardiovascular Care Association
  413. The use of echocardiography in acute cardiovascular care: Recommendations of the European Association of Cardiovascular Imaging and the Acute Cardiovascular Care Association
  414. Impact of time to cooling initiation and time to target temperature in patients treated with hypothermia after cardiac arrest
  415. Predictors of one-year mortality at hospital discharge after acute coronary syndromes: A new risk score from the EPICOR (long-tErm follow uP of antithrombotic management patterns In acute CORonary syndrome patients) study
  416. 2014 ESC/ESA Guidelines on non-cardiac surgery
  417. Effect of Low Perceived Social Support on Health Outcomes in Young Patients With Acute Myocardial Infarction: Results From the VIRGO (Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients) Study
  418. Contemporary inter-hospital transfer patterns for the management of acute coronary syndrome patients: Findings from the EPICOR study
  419. Shunt active power filter for harmonic compensation of two-phase nonlinear loads
  420. 2014 ESC/EACTS Guidelines on myocardial revascularization
  421. Guidelines on Aortic diseases
  422. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
  423. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
  424. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) * Developed with the special contribu...
  425. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group ...
  426. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management
  427. Effectiveness of a pilot intervention to reduce abciximab-related bleeding in patients with acute coronary syndromes
  428. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD – Summary
  429. ADMISSION HYPERGLYCEMIA IMPROVES THE GRACE RISK SCORE FOR PREDICTION OF IN-HOSPITAL MORTALITY: INSIGHTS FROM THE EURO HEART SURVEY ACS III
  430. Duración del tratamiento antiagregante en el síndrome coronario agudo
  431. 2013 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy
  432. Are Available Electrocardiographic Methods Accurate Enough to Diagnose Ventricular Tachycardia in the Emergency Department?
  433. Hospital readmission performance and patterns of readmission: retrospective cohort study of Medicare admissions
  434. Wytyczne ESC dotyczące cukrzycy, stanu przedcukrzycowego i chorób układu sercowo- -naczyniowego opracowane we współpracy z EASD
  435. Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: Design of the MUSICA-2 randomized trial
  436. Impact of Frailty and Functional Status on Outcomes in Elderly Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty: Rationale and Design of the IFFANIAM Study
  437. TCT-215 Predictors of 1-year mortality at hospital discharge after ACS STEMI and NSTE-ACS: a new risk score from the EPICOR study
  438. Cardiovascular and upper gastrointestinal bleeding consequences of low-dose acetylsalicylic acid discontinuation
  439. Association Between Obesity and Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Operations: A Systematic Review and Meta-Analysis
  440. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
  441. 2013 ESC guidelines on the management of stable coronary artery disease
  442. Euro Heart Survey 2009 Snapshot: regional variations in presentation and management of patients with AMI in 47 countries
  443. Gender differences in the use of invasive strategies and recommended medications for AMI in the EHS 2009 snapshot registry
  444. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a low-moderate CHADS2 score?
  445. Should we recommend triple therapy in elderly patients with atrial fibrillation submitted to coronary stenting?
  446. Triple therapy for all patients with atrial fibrillation undergoing coronary stenting?
  447. Ability of non-dependent elderly patients hospitalized for heart failure to perform the tasks required for self-care
  448. Prevalence of frailty in elderly non-dependent patients hospitalized for heart failure, and characteristics of frail patients
  449. Outcomes in patients with atrial fibrillation undergoing coronary artery stenting with a low-moderate CHA2DS2VASc score: do they need anticoagulation?
  450. New-onset atrial fibrillation and prognosis in nonagenarians after acute myocardial infarction
  451. 2013 ESH/ESC Guidelines for the management of arterial hypertension
  452. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
  453. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Associati...
  454. Acute heart failure as presentation of left-ACAOS
  455. 2013 ESH/ESC Guidelines for the management of arterial hypertension
  456. 2013 ESH/ESC Guidelines for the management of arterial hypertension
  457. Analytic comments of the initial results of the VISION (Vascular events In noncardiac Surgery patIents cOhort evaluatioN): Association between troponin T and mortality at 30 days in noncardiac surgery patients
  458. Are Elderly Patients with Acute Coronary Syndromes Undertreated? Data from Euro Heart Survey on ACS III Registry
  459. ASSOCIATION BETWEEN OBESITY AND POSTOPERATIVE ATRIAL FIBRILLATION IN PATIENTS UNDERGOING CARDIAC SURGERY: A SYSTEMATIC REVIEW AND META-ANALYSIS
  460. Diagnoses and Timing of 30-Day Readmissions After Hospitalization for Heart Failure, Acute Myocardial Infarction, or Pneumonia
  461. EPICOR (long-tErm follow-up of antithrombotic management Patterns In acute CORonary syndrome patients) study: rationale, design, and baseline characteristics
  462. Refractory cardiogenic shock following idiopathic giant cell myocarditis in a 19-year-old woman
  463. Error in Viewpoint in: Statin Therapy for Healthy Men Identified as ‘Increased Risk,’
  464. Acute coronary syndromes: considerations for improved acceptance and implementation of management guidelines
  465. Discontinuation of low-dose acetylsalicylic acid therapy in UK primary care: incidence and predictors in patients with cardiovascular disease
  466. HOSPITAL PERFORMANCE IS NOT ASSOCIATED WITH THE TIMING OR CAUSES OF 30-DAY READMISSION AFTER HOSPITALIZATION FOR HEART FAILURE OR ACUTE MYOCARDIAL INFARCTION
  467. Predictors and time trends in clopidogrel and proton pump inhibitor coprescription with low-dose acetylsalicylic acid
  468. Guía de práctica clínica de la ESC para el manejo del síndrome coronario agudo en pacientes sin elevación persistente del segmento ST
  469. ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation
  470. Use of risk scores in acute coronary syndromes
  471. Differential Effect of β-Blockers for Heart Rate Control in Coronary Artery Disease
  472. TCT-383: Effect of chronic use of vitamin K antagonists on in-hospital outcome of patients presenting with acute coronary syndromes. Data from 19 000 patients from Euro Heart Survey ACS III registry (2006-2008)
  473. Cluster-randomized trial to evaluate the effects of a quality improvement program on management of non–ST-elevation acute coronary syndromes: The European Quality Improvement Programme for Acute Coronary Syndromes (EQUIP-ACS)
  474. Tratamiento extrahospitalario y en Urgencias del síndrome coronario agudo sin elevación del segmento ST
  475. Tratamiento extrahospitalario y en Urgencias del síndrome coronario agudo con elevación persistente del segmento ST
  476. Dolor torácico agudo
  477. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment eleva...
  478. Kounis syndrome secondary to amoxicillin use in an asthmatic patient
  479. Prevalence of geriatric syndromes and impact on clinical and functional outcomes in older patients with acute cardiac diseases
  480. 480 CLINICAL AND ECONOMIC IMPACT OF ANTITHROMBOTIC MANAGEMENT PATTERNS IN ACUTE CORONARY SYNDROMES: RATIONALE AND DESIGN OF THE EPICOR STUDY
  481. DETERMINANTS OF STROKE AND ITS IMPACT ON OUTCOME OF ACS IN CLINICAL PRACTICE IN EUROPE: LESSONS FROM THE EURO HEART SURVEY ACS REGISTRY
  482. IMPROVEMENT OF EARLY INVASIVE TREATMENT FOR NSTE-ACS OVER TIME IN CLINICAL PRACTICE IN EUROPE: LESSONS FROM THE EURO HEART SURVEY ACS REGISTRY
  483. AS-048 In-Hospital Outcome of Patients with Acute Coronary Syndromes and Anemia at Presentation. Euro Heart Survey ACS III Registry (2006-2008)
  484. AS-098 Primary PCI with DES Implantation in Patients with STEMI/LBBB. Euro Heart Survey ACS III Registry (2006-2008)
  485. PERFORMANCE MEASURES IN ST SEGMENT ELEVATION MYOCARDIAL INFARCTION: 2 YEARS TEMPORAL CHANGES AND ROOM FOR IMPROVEMENT. INSIGHTS FROM THE EURO HEART SURVEY ACS III REGISTRY
  486. VALUE OF KILLIP CLASSIFICATION FIRST DESCRIBED IN 1,967 FOR RISK STRATIFICATION OF STEMI AND NSTE-ACS IN THE NEW MILLENNIUM: LESSONS FROM THE EURO HEART SURVEY ACS REGISTRY
  487. NSAID Use Selectively Increases the Risk of Non-Fatal Myocardial Infarction: A Systematic Review of Randomised Trials and Observational Studies
  488. Insulin Receptor Substrate-1 Expression Is Increased in Circulating Leukocytes of Patients with Acute Coronary Syndrome
  489. “Do GRACE (Global Registry of Acute Coronary events) risk scores still maintain their performance for predicting mortality in the era of contemporary management of acute coronary syndromes?”
  490. Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients (VIRGO) Study Design
  491. The future of clinical trials in secondary prevention after acute coronary syndromes
  492. Primary angioplasty vs. fibrinolysis in very old patients with acute myocardial infarction: TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos) randomized trial and pooled analysis with previous studies
  493. A review of international pharmacoeconomic models assessing the use of aspirin in primary prevention
  494. Trends in Length of Stay and Short-term Outcomes Among Medicare Patients Hospitalized for Heart Failure, 1993-2006
  495. Is Same-Hospital Readmission Rate a Good Surrogate for All-Hospital Readmission Rate?
  496. Use of Non-Steroidal Antiinflammatory Drugs and Type-Specific Risk of Acute Coronary Syndrome
  497. Análisis coste-efectividad del uso a largo plazo de clopidogrel en el manejo de los pacientes con infarto agudo de miocardio con elevación del segmento ST en España
  498. Hospital Volume and 30-Day Mortality for Three Common Medical Conditions
  499. USE OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND TYPE-SPECIFIC RISK OF ACUTE CORONARY SYNDROME
  500. MAJOR BLEEDING COMPLICATIONS IN PATIENTS WITH STEMI ACCOUNT FOR A DOUBLING IN HOSPITAL MORTALITY IN CLINICAL PRACTICE: LESSONS FROM THE EURO HEART SURVEY ACS REGISTRY
  501. The role of cardiac registries in evidence-based medicine
  502. The relationship between systolic blood pressure on admission and mortality in older patients with heart failure
  503. Prediction of 30-Day Mortality in Older Patients with a First Acute Myocardial Infarction
  504. Improving the management of non-ST elevation acute coronary syndromes: systematic evaluation of a quality improvement programme European QUality Improvement Programme for Acute Coronary Syndrome: The EQUIP-ACS project
  505. Latest Strategies and Patient Outcomes in the Treatment of ST-segment-elevation Myocardial Infarction
  506. Recent National Trends in Readmission Rates After Heart Failure Hospitalization
  507. Patient Registries of Acute Coronary Syndrome: Assessing or Biasing the Clinical Real World Data?
  508. Pronóstico y manejo de los pacientes con síndrome coronario agudo y enfermedad polivascular
  509. Prognosis and Management of Patients With Acute Coronary Syndrome and Polyvascular Disease
  510. Differences in Medical Treatment of Chronic Coronary Heart Disease Patients According to Medical Specialities
  511. Mejora del pronóstico tras parada cardiorrespiratoria de causa cardiaca mediante el empleo de hipotermia moderada: comparación con un grupo control
  512. Control de los factores de riesgo y tratamiento de los pacientes con cardiopatía isquémica: registro TRECE
  513. Control of Risk Factors in and Treatment of Patients With Coronary Heart Disease: The TRECE Study
  514. Improved Prognosis After Using Mild Hypothermia to Treat Cardiorespiratory Arrest Due to a Cardiac Cause: Comparison With a Control Group
  515. Therapeutic strategies after coronary stenting in chronically anticoagulated patients: the MUSICA study
  516. Comparison of Treatment and Outcome of Acute Coronary Syndrome in Patients With Versus Patients Without Diabetes Mellitus
  517. Respuesta
  518. Response
  519. The joint contribution of sex, age and type of myocardial infarction on hospital mortality following acute myocardial infarction
  520. Patterns of use and effectiveness of early invasive strategy in non–ST-segment elevation acute coronary syndromes: An assessment by propensity score
  521. Dolor torácico en urgencias: frecuencia, perfil clínico y estratificación de riesgo
  522. Estudio MASCARA (Manejo del Síndrome Coronario Agudo. Registro Actualizado). Resultados globales
  523. Evaluación de una intervención para mejorar la prevención secundaria en pacientes sometidos a cirugía cardiaca
  524. Diabetes mellitus tipo 2 y enfermedad cardiovascular en España: una revisión descriptiva
  525. Chest Pain in the Emergency Department: Incidence, Clinical Characteristics, and Risk Stratification
  526. Influencia del sexo en la mortalidad y el manejo del síndrome coronario agudo en España
  527. MASCARA (Manejo del Síndrome Coronario Agudo. Registro Actualizado) Study. General Findings
  528. The Value of an Intervention for Improving Secondary Prevention in Patients Undergoing Cardiac Surgery
  529. Positive non-invasive tests in the chest pain unit: importance of the clinical profile for estimating the probability of coronary artery disease
  530. Treatment and outcomes of severe cardiac disease with surgical indication in very old patients
  531. Unidades coronarias de cuidados intermedios: base racional, infraestructura, equipamiento e indicaciones de ingreso
  532. Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups
  533. Actualización en cardiopatía isquémica 2006
  534. Angina de pecho estable. Trascendencia clínica en la era de la intervención, limitaciones y avances actuales de su terapia farmacológica
  535. Intermediate Coronary Care Units: Rationale, Infrastructure, Equipment, and Referral Criteria
  536. Magnitude and consequences of undertreatment of high-risk patients with non-ST segment elevation acute coronary syndromes: insights from the DESCARTES Registry
  537. The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004
  538. Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes
  539. Actualización en cardiopatía isquémica 2005
  540. Estrategia invasiva en el SCASEST. Tratamiento antitrombótico
  541. Coronary care unit admission of very old patients with acute myocardial infarction
  542. Respuesta
  543. Short- and Long-Term Cost-Effectiveness Analysis of Adding Clopidogrel to Standard Therapy in Acute Coronary Syndrome Patients in Spain
  544. Do We Need a Randomized Trial (TRIANA) on Reperfusion in Patients Aged Over 75 Years?: Reply
  545. Análisis de la relación coste-efectividad a corto y largo plazo de clopidogrel añadido a terapia estándar en pacientes con síndrome coronario agudo en España
  546. Mechanisms of death in elderly patients with acute myocardial infarction exposed to fibrinolytic therapy: reply
  547. Bases conceptuales y metodológicas del estudio MASCARA: el reto de la efectividad
  548. Influence of Age on Gender Differences in the Management of Acute Inferior or Posterior Myocardial Infarction
  549. Un nuevo índice de riesgo para pacientes con ECG normal o no diagnóstico ingresados en la unidad de dolor torácico
  550. A New Risk Score for Patients With a Normal or Non-Diagnostic ECG Admitted to a Chest Pain Unit
  551. Influence of Reperfusion Therapy on Prognosis in Patients Aged ≥89 Years With Acute Myocardial Infarction
  552. Effect of thrombolytic therapy on the risk of cardiac rupture and mortality in older patients with first acute myocardial infarction†
  553. Tratamiento y evolución a corto plazo de los ancianos con infarto agudo de miocardio ingresados en hospitales con disponibilidad de angioplastia primaria. El Registro TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos)
  554. Características y mortalidad del infarto agudo de miocardio tratado con intervencionismo coronario percutáneo primario en España. Resultados del Registro TRIANA 1 (TRatamiento del Infarto Agudo de miocardio eN Ancianos)
  555. Characteristics and Mortality Following Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction in Spain. Results From the TRIANA 1 (TRatamiento del Infarto Agudo de miocardio eN Ancianos) Registry
  556. Type of Treatment and Short-Term Outcome in Elderly Patients With Acute Myocardial Infarction Admitted to Hospitals With a Primary Coronary Angioplasty Facility. The TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos) Registry
  557. Manejo del síndrome coronario agudo sin elevación del segmento ST en España. Estudio DESCARTES (Descripción del Estado de los Síndromes Coronarios Agudos en un Registro Temporal ESpañol)
  558. Management of Non-ST-Segment-Elevation Acute Coronary Syndromes in Spain. The DESCARTES (Descripción del Estado de los Síndromes Coronarios Agudos en un Registro Temporal ESpañol) Study
  559. Fatal retroperitoneal haemorrhage associated with enoxaparin and impaired renal function
  560. Actualización en cardiopatía isquémica 2004
  561. Introducción: puntos clave en el manejo del síndrome coronario agudo sin elevación del segmento ST
  562. Elección del tratamiento antitrombótico en pacientes con síndrome coronario agudo sin elevación del segmento ST de alto riesgo
  563. Ejemplos de intervenciones para mejorar la calidad de la atención al síndrome coronario agudo sin elevación del segmento ST
  564. Acute myocardial infarction caused by paradoxical tumorous embolism as a manifestation of hepatocarcinoma
  565. 1128-131 Do elderly patients with acute myocardial infarction show the “smoker's paradox”? results from the PPRIMM75 registry
  566. Infrautilización del ácido acetilsalicílico en la prevención cardiovascular del paciente con diabetes mellitus
  567. Infrautilización del ácido acetilsalicílico en la prevención cardiovascular del paciente con diabetes mellitus
  568. Thrombolytic therapy but not primary angioplasty is associated with an early hazard in patients > 75 years old with acute myocardial infarction: Results of the PPRIMM75 registry
  569. P2340 Homocysteine levels and prognosis after myocardial infarction in older patients
  570. 133 Is the smokers paradox present in older patients with acute myocardial infarction? Results of the PPRIMM75 registry
  571. Aplicabilidad de la nueva definición de infarto de miocardio y opinión de los cardiólogos españoles
  572. Aplicabilidad de la nueva definición de infarto de miocardio y opinión de los cardiólogos españoles
  573. Critical sets of nonlinear Sturm-Liouville operators of Ambrosetti-Prodi type
  574. Remarks about the geometry of the Ambrosetti–Prodi problem
  575. Prevención y tratamiento de la cardiopatía isquémica en pacientes con diabetes mellitus
  576. Actualización (2002) de las Guías de Práctica Clínica de la Sociedad Española de Cardiología en angina inestable/infarto sin elevación del segmento ST
  577. Manejo de la insuficiencia cardíaca en el anciano ¿Quién y dónde? Visión del especialista
  578. Right ventricular involvement increases mortality only in the acute phase of inferior myocardial infarction and only in elderly patients Hector Bueno, Ramon Lopez-Palop, Esther Perez-David, Manuel Martinez-Selles, Ana Herranz. Hospital General Universi...
  579. Aspectos específicos de la insuficiencia cardíaca en geriatría, en los jóvenes y en la mujer. aspectos clínicos y diagnósticos
  580. Ischemic Heart Disease in the Elderly: A Need to Understand the Causes of High Mortality After Acute Myocardial Infarction
  581. Early Prognostic Assessment and Treatment of Acute Myocardial Infarction in the Elderly
  582. Clinical Cardiology in the Elderly
  583. Guías de práctica clínica de la Sociedad Española de Cardiología en la angina inestable/infarto sin elevación ST
  584. Blood strontium concentration related to the length of the agonal period in seawater drowning cases
  585. Pulmonary venous flow in hypertrophic cardiomyopathy as assessed by the transoesophageal approach The additive value of pulmonary venous flow and left atrial size variables in estimating the mitral inflow pattern in hypertrophic cardiomyopathy
  586. Combined Effect of Age and Right Ventricular Involvement on Acute Inferior Myocardial Infarction Prognosis
  587. Walking and Mortality in Older Men
  588. Mechanical Complications After Acute Myocardial Infarction in the Elderly: Incidence, Predictors and Outcome
  589. Predictors of Free Wall Rupture in Acute Inferior Myocardial Infarction
  590. Short- and Long-term Prognosis of Elderly Patients With First Acute Inferior Myocardial Infarctions
  591. In-Hospital Outcome of Elderly Patients With Acute Inferior Myocardial Infarction and Right Ventricular Involvement
  592. Predicción clínica del pronóstico precoz en el infarto agudo de miocardio
  593. Clinical and Echocardiographic Findings in HIV Patients with Pericardial Effusion
  594. Effects of dobutamine on doppler echocardiographic indexes of aortic stenosis
  595. Incidence and Clinical Significance of Multiple Consecutive, Appropriate, High-Energy Discharges in Patients With Implanted Cardioverter-Defibrillators
  596. Outcome of right ventricular infarction in elderly patients
  597. High short-term mortality of elderly patients with first acute inferior myocardial infarctions
  598. Influence of Sex on the Short-term Outcome of Elderly Patients With a First Acute Myocardial Infarction
  599. The Importance of Antitachycardia Pacing for Patients Presenting with Ventricular Tachycardia
  600. Transesophageal echocardiographic detection of atrial wall aneurysm as a result of abnormal attachment of mitral prosthesis
  601. Left atrial appendage doppler flow patterns: Implications on thrombus formation
  602. Airborne plume study of emissions from the processing of copper ores in southeastern Arizona